Improving the Prognostic Ability for Personalized Therapeutic Approaches in Nonseminomatous Germ Cell Tumors

Andrea Necchi¹, Jeffrey S Ross^{2

3}, Philippe E Spiess⁴

Affiliations

¹ Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.
² Upstate Medical University, Syracuse, NY.
³ Foundation Medicine, Cambridge, MA.
⁴ Moffitt Cancer Center and Research Institute, Tampa, FL.

Comment

Andrea Necchi et al. J Clin Oncol. 2019.

. 2019 Sep 10;37(26):2314-2316.

doi: 10.1200/JCO.19.01672. Epub 2019 Jul 30.

Andrea Necchi¹, Jeffrey S Ross^{2

3}, Philippe E Spiess⁴

¹ Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.
² Upstate Medical University, Syracuse, NY.
³ Foundation Medicine, Cambridge, MA.
⁴ Moffitt Cancer Center and Research Institute, Tampa, FL.

No abstract available

Comment on

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
Funt SA, Patil S, Feldman DR, Motzer RJ, Bajorin DF, Sheinfeld J, Tickoo SK, Reuter VE, Bosl GJ. Funt SA, et al. J Clin Oncol. 2019 Sep 10;37(26):2329-2337. doi: 10.1200/JCO.18.01608. Epub 2019 Jun 24. J Clin Oncol. 2019. PMID: 31233353 Free PMC article.